DNA ploidy and nuclear morphometry for the classification of dysplastic nevi

Analytical and Quantitative Cytology and Histology

Volumn 21, Issue 5, 1999, Pages 437-444

  Williams, Richard A ^a   Baak, Jan P A ^b   Meijer, Gerrit A ^b   Charlton, Ian G ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c Wangaratta and Dist Pathol Service   (Australia)

Author keywords

Cell nucleus; DNA; Morphometry; Nevus, dysplastic; Ploidies

Indexed keywords

CELL DNA;

ADULT; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC VALUE; DYSPLASTIC NEVUS; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; MORPHOMETRICS; PLOIDY; PRIORITY JOURNAL;

ADULT; CELL NUCLEUS; DIAGNOSIS, DIFFERENTIAL; DISCRIMINANT ANALYSIS; DNA, NEOPLASM; DYSPLASTIC NEVUS SYNDROME; HUMANS; IMAGE CYTOMETRY; KARYOMETRY; MELANOMA; NEVUS, INTRADERMAL; PLOIDIES; SKIN NEOPLASMS;

EID: 0032717753     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ackerman AB: A critique of an N.I.H. consensus development conference about "early" melanoma. Am J Dermatopathol 1993;15:52-59
2. Ackerman AB: What naevus is dysplastic, a syndrome and the commonest precursor of malignant melanoma?: A riddle and an answer. Histopathology 1988;13:241-256
3. Ackerman AB, Milde P: Naming acquired melanocytic nevi: Common and dysplastic, normal and atypical, or Unna, Meischer, Spitz, and Clark. Am J Dermatopathol 1992; 14:447-453
4. Bergman W, Ruiter DJ, Scheffer E, van Vloten WA: Melanocytic atypia in dysplastic nevi: Immunohistochemical and cytophotometrical analysis. Cancer 1988;61: 1660-1666
5. Bjornhagen V, Bonfoco E, Mansson Brahme EM, Lindholm J, Auer G: Morphometric, DNA, and proliferating cell nuclear antigen measurements in benign melanocytic lesions and cutaneous malignant melanoma. Am J Dermatopathol 1994; 16:615-623
6. Clark WH Jr, Reimer RR, Greene M, Ainsworth AM, Mastrangelo MJ: Origin of familial melanoma from heritable melanocytic lesions: "The B-K mole syndrome." Arch Dermatol 1978;114:732-738
7. De Witt PEJ, van't Hof-Grootenboer B, Ruiter DJ, Bondi R, Brocker EB, Cesarini JP, Hastrup N, Hou-Jensen K, MacKie RM, Scheffer E, Suter L, Urso C: Validity of the histopathological criteria used for diagnosing dysplastic naevi. Eur J Cancer 1993;29A:831-839
8. Duray PH, DerSimonian R, Barnhill R, Stenn K, Ernstoff MS, Fine J, Kirkwood JM: An analysis of interobserver recognition of the histopathological features of dysplastic nevi from a mixed group of nevomelanocytic lesions. J Am Acad Dermatol 1992;27:741-749
9. Elder DE, Greene MH, Guerry D IV, Kraemer KH, Clark WH Jr: The dysplastic nevus syndrome: Our definition. Am J Dermatopathol 1982;4:455-460
10. Elder DE, Murphy GF: Melanocytic Tumors of the Skin. In Atlas of Tumour Pathology. Third series, fascicle 2. Washington, DC, Armed Forces Institute of Pathology, 1991
11. Fand SB: Environmental conditions for optimal Feulgen hydrolysis. In Introduction to Quantitative Cytochemistry II. Edited by GL Wied, GF Bahr. New York, Academic Press, 1970, pp 209-294
12. Gruis NA, van der Velden PA, Sandkuijl LA, Prins DE, Weaver-Feldhaus J, Kamb A, Bergman W, Frants RR: Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds (lett). Nat Genet 1995;10: 351-353
13. Kamb A, Shattuck-Eidens D, Eeles R, Lui Q, Gruis NA, Ding W, Hussey C, Tran T, Miki Y, Weaver-Feldhaus J, McClure M, Aitken JF, Anderson DE, Bergman W, Frants R, Goldgar DE, Green A, MacLennan R, Martin NG, Meyer LJ, Youl P, Zone JJ, Skolnick MH, Cannon-Albright LA: Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet 1994;8:23-26
14. Lynch HT, Frichot BC, Lynch JF: Familial atypical multiple mole-melanoma syndrome. J Med Genet 1978;15:352-356
15. Roth ME, Grant-Kels JM, Ackerman AB, Elder DE, Friedman RJ, Heilman ER, Maize JC, Sagebiel RW: The histopathology of dysplastic nevi: Continued controversy. Am J Dermatopathol 1991;13:38-51
16. Sagebiel RW: Diagnosis and management of premalignant melanocytic proliferations. Pathology 1985;17:285-290
17. Smoller BR, Egbert BM: Dysplastic naevi can be diagnosed and graded reproducibly: A longitudinal study. J Am Acad Dermatol 1992;27:399-402
18. Williams RA, Baak JPA, Meijer G, Charlton I: Testing the value of a measurement protocol for DNA image cytometry and comparison of different cytological preparations. Analyt Quant Cytol Histol 1996;18:429-437
19. Williams RA, Baak JPA, Meijer GA, Charlton IG: Further testing of the value of a measurement protocol for DNA ploidy studies using image cytometry: Comparison of results obtained from cytological and paraffin section preparations. Analyt Quant Cytol Histol 1996;8:345-350
20. Williams RA, Baak JPA, Meijer GA, Rees J: Evaluation of interobserver reproducibility for the classification of benign compound naevi, dysplastic naevi and malignant melanomas and of individual histologically important diagnostic features for the diagnosis of dysplastic naevi (unpublished)